|
itraconazole |
|
CHEBI:6076 |
|
An N-arylpiperazine that is cis-ketoconazole in which the imidazol-1-yl group is replaced by a 1,2,4-triazol-1-yl group and in which the actyl group attached to the piperazine moiety is replaced by a p-[(±)1-sec-butyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]phenyl group. A potent P-glycoprotein and CYP3A4 inhibitor, it is used as an antifungal drug for the treatment of various fungal infections, including aspergillosis, blastomycosis, candidiasis, chromoblastomycosis, coccidioidomycosis, cryptococcosis, histoplasmosis, and sporotrichosis. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
eMolecules:29541763, eMolecules:902000, eMolecules:36753603, Selleckchem:Itraconazole(Sporanox) |
|
Molfile
XML
SDF
|
|
more structures >>
|
|
|
InChI=1S/C35H38Cl2N8O4/c1- 3- 25(2) 45- 34(46) 44(24- 40- 45) 29- 7- 5- 27(6- 8- 29) 41- 14- 16- 42(17- 15- 41) 28- 9- 11- 30(12- 10- 28) 47- 19- 31- 20- 48- 35(49- 31,21- 43- 23- 38- 22- 39- 43) 32- 13- 4- 26(36) 18- 33(32) 37/h4- 13,18,22- 25,31H,3,14- 17,19- 21H2,1- 2H3/t25?,31- ,35- /m0/s1 |
VHVPQPYKVGDNFY-ZPGVKDDISA-N |
CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
Hedgehog signaling pathway inhibitor
Any pathway inhibitor that inhibits the Hedgehog signalling pathway.
P450 inhibitor
An enzyme inhibitor that interferes with the activity of cytochrome P450 involved in catalysis of organic substances.
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor
An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of xenobiotic-transporting ATPase (EC 3.6.3.44).
antifungal drug
Any antifungal agent used to prevent or treat fungal infections in humans or animals.
(via conazole antifungal drug )
(via triazole antifungal drug )
ergosterol biosynthesis inhibitor
Any compound that inhibits one or more steps in the pathway leading to the synthesis of ergosterol.
(via conazole antifungal agent )
antifungal agent
An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
(via conazole antifungal agent )
(via triazole antifungal agent )
|
|
antifungal drug
Any antifungal agent used to prevent or treat fungal infections in humans or animals.
(via conazole antifungal drug )
(via triazole antifungal drug )
|
|
View more via ChEBI Ontology
2- (butan- 2- yl)- 4- {4- [4- (4- {[(2R,4S)- 2- (2,4- dichlorophenyl)- 2- (1H- 1,2,4- triazol- 1- ylmethyl)- 1,3- dioxolan- 4- yl]methoxy}phenyl)piperazin- 1- yl]phenyl}- 2,4- dihydro- 3H- 1,2,4- triazol- 3- one
|
itraconazole
|
UniProt
|
Itraconazole
|
KEGG DRUG
|
Itrizole (TN)
|
KEGG DRUG
|
Oriconazole
|
ChemIDplus
|
Sporanox (TN)
|
KEGG DRUG
|
84625-61-6
|
CAS Registry Number
|
KEGG DRUG
|
84625-61-6
|
CAS Registry Number
|
ChemIDplus
|
11219548
|
PubMed citation
|
Europe PMC
|
11403818
|
PubMed citation
|
Europe PMC
|
11422002
|
PubMed citation
|
Europe PMC
|
15521894
|
PubMed citation
|
Europe PMC
|
19025521
|
PubMed citation
|
Europe PMC
|
20400651
|
PubMed citation
|
Europe PMC
|
25326091
|
PubMed citation
|
Europe PMC
|
|